More Like this

1. ACE2 glycans preferentially interact with SARS-CoV-2 over SARS-CoV

   https://doi.org/10.1039/d1cc02305e  

   Acharya, Atanu; Lynch, Diane L.; Pavlova, Anna; Pang, Yui Tik; Gumbart, James C. (June 2021, Chemical Communications)

   We report a distinct difference in the interactions of the glycans of the host-cell receptor, ACE2, with SARS-CoV-2 and SARS-CoV S–protein receptor-binding domains (RBDs). Our analysis demonstrates that the ACE2 glycan at N322 enhances interactions with the SARS-CoV-2 RBD while the ACE2 glycan at N90 may offer protection against infections of both coronaviruses depending on its composition. The interactions of the ACE2 glycan at N322 with SARS-CoV RBD are blocked by the presence of the RBD glycan at N357 of the SARS-CoV RBD. The absence of this glycosylation site on SARS-CoV-2 RBD may enhance its binding with ACE2. 

   more » « less
2. Reducing transmission of SARS-CoV-2

   https://doi.org/10.1126/science.abc6197  

   Prather, Kimberly A.; Wang, Chia C.; Schooley, Robert T. (June 2020, Science)

   null (Ed.)
3. Airborne transmission of SARS-CoV-2

   https://doi.org/10.1126/science.abf0521  

   Prather, Kimberly A.; Marr, Linsey C.; Schooley, Robert T.; McDiarmid, Melissa A.; Wilson, Mary E.; Milton, Donald K. (October 2020, Science)

   Sills, Jennifer (Ed.)
4. Emerging dominant SARS-CoV-2 variants

   Jiahui Chen; Rui Wang; Yuta Hozumi; Gengzhuo Liu; Yuchi Qiu; Xiaoqi Wei; Guo-Wei Wei (January 2023, Journal of chemical information and modeling)
5. Mutations Strengthened SARS-CoV-2 Infectivity

   https://doi.org/10.1016/j.jmb.2020.07.009  

   Chen, Jiahui; Wang, Rui; Wang, Menglun; Wei, Guo-Wei (September 2020, Journal of Molecular Biology)

   null (Ed.)